Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
about
Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.
P2860
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
@ast
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
@en
type
label
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
@ast
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
@en
prefLabel
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
@ast
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
@en
P356
P1433
P1476
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
@en
P2093
Bischoff W
P2888
P304
P356
10.1007/BF01661306
P478
14 Suppl 4
P577
1986-01-01T00:00:00Z